ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 63 filers reported holding ENTRADA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $120,000 | +650.0% | 8,422 | +636.2% | 0.00% | – |
| Q1 2024 | $16,000 | -85.0% | 1,144 | -83.9% | 0.00% | – |
| Q4 2023 | $107,000 | +81.4% | 7,085 | +90.3% | 0.00% | – |
| Q3 2023 | $59,000 | +73.5% | 3,724 | +66.8% | 0.00% | – |
| Q2 2023 | $34,000 | – | 2,233 | +7875.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 28 | -95.7% | 0.00% | – |
| Q1 2022 | $6,000 | -81.2% | 646 | -65.3% | 0.00% | – |
| Q4 2021 | $32,000 | – | 1,863 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,425,784 | $75,769,000 | 16.37% |
| 5AM Venture Management, LLC | 4,408,379 | $75,471,000 | 14.16% |
| 72 Investment Holdings, LLC | 509,024 | $8,714,000 | 7.73% |
| TCG Crossover Management, LLC | 663,694 | $11,362,000 | 5.32% |
| Redmile Group, LLC | 1,954,420 | $33,460,000 | 0.76% |
| StepStone Group LP | 761,277 | $13,033,000 | 0.74% |
| Baker Brothers Advisors | 4,704,419 | $80,540,000 | 0.39% |
| Avidity Partners Management LP | 255,000 | $4,366,000 | 0.09% |
| MOORE CAPITAL MANAGEMENT, LP | 105,000 | $1,798,000 | 0.04% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 106,000 | $1,815,000 | 0.04% |